MedPath

Tongji-Ezhou Study

Recruiting
Conditions
Nutritional and Metabolic Diseases
Metabolic Syndrome
Risk Factor, Cardiovascular
Diabetes
Cardiovascular Diseases
Obesity
Environmental Exposure
Interventions
Other: Dietary and environmental exposure (Observational study)
Registration Number
NCT03845868
Lead Sponsor
Huazhong University of Science and Technology
Brief Summary

Tongji-Ezhou study (TJEZ) is a prospective cohort study launched at 2013 in EZhou city, Hubei province, with the goal of recruiting and assessing 10,000 individuals and then following them for at least 2 decades. In addition, blood samples would be collected every 3-5 years among 6000 of them to investigate the nutritional biomarkers and potential determinants of chronic diseases such as obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study.
Exclusion Criteria
  • (i) with chemotherapy or radiotherapy for cancer and other severe diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ezhou CDC physical examination centerDietary and environmental exposure (Observational study)-
Egang hospital physical examination centerDietary and environmental exposure (Observational study)-
Primary Outcome Measures
NameTimeMethod
Diabetic complicationsmean follow up of 10 years

Development of diabetic complications

Incidence of diabetes5 years

Type 2 diabetes was diagnosed when FPG ≥ 7.0 mmol/L and/or OGTT2h ≥ 11.1 mmol/L, or using diabetic medication (self-report).

Incidence of metabolic syndrome5 years

Metabolic syndrome is defined as using the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. These criteria require three or more of the following components: (1) central obesity (waist circumference of ≥90 cm for men or ≥80 cm for women), (2) triglycerides of ≥1.7 mmol/L, (3) HDL-C of \<1.03 mmol/L for men or \<1.30 mmol/L for women, (4) blood pressure of ≥130/85 mmHg or on medication for hypertension, and (5) fasting glucose of ≥5.6 mmol/L.

Incidence of cardiovascular diseasesmean follow up of 10 years

Cardiovascular death, stroke, myocardial infarction, heart failure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath